Table of Contents

August 1, 2006; 145 (3)

Articles

  • Victims of Cardiac Arrest Occurring Outside the Hospital: A Source of Transplantable Kidneys

    • Ana I. Sánchez-Fructuoso,
    • Maria Marques,
    • Dolores Prats,
    • José Conesa,
    • Natividad Calvo,
    • M. Jesús Pérez-Contín,
    • Jesús Blazquez,
    • Cristina Fernández,
    • Ervigio Corral,
    • Francisco Del Río,
    • Jose R. Núñez,
    • and Alberto Barrientos
    Ann Intern Med August 1, 2006 145:157-164

    Spanish law allows physicians to maintain circulation in people brought to the hospital after cardiac arrest until it is possible to contact relatives for permission to harvest organs for donation. In this case series from Madrid, Spain, graft survival at 1 and 5 years in 320 recipients of kidneys from such “non–heart-beating” donors was similar to that in 458 recipients of cadaver kidneys from heart-beating donors age 60 years or younger.

  • Improving Blood Pressure Control through Provider Education, Provider Alerts, and Patient Education: A Cluster Randomized Trial

    • Christianne L. Roumie,
    • Tom A. Elasy,
    • Robert Greevy,
    • Marie R. Griffin,
    • Xulei Liu,
    • William J. Stone,
    • Kenneth A. Wallston,
    • Robert S. Dittus,
    • Vincent Alvarez,
    • Janice Cobb,
    • and Theodore Speroff
    Ann Intern Med August 1, 2006 145:165-175

    The authors randomly assigned providers caring for hypertensive patients to 1 of 3 interventions: 1) a Web link to the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; 2) the Web link and a computer reminder of the patient's blood pressure; or 3) the Web link, the computer alert, and a letter to their patients about ways to control their blood pressure. Patients of providers assigned to the third group had better blood pressure control.

  • Endogenous Sex Hormones and Cardiovascular Disease Incidence in Men

    • Johan Ärnlöv,
    • Michael J. Pencina,
    • Shreyasee Amin,
    • Byung-Ho Nam,
    • Emelia J. Benjamin,
    • Joanne M. Murabito,
    • Thomas J. Wang,
    • Philip E. Knapp,
    • Ralph B. D'Agostino, Sr.,
    • Shalendar Bhasin,
    • and Ramachandran S. Vasan
    Ann Intern Med August 1, 2006 145:176-184

    A total of 2084 men from 2 Framingham Heart Study cohorts had 1 measurement of total serum estrogen, testosterone, and dehydroepiandrosterone sulfate (DHEA-S), followed by 10 years of monitoring for cardiovascular disease (CVD) outcomes. Testosterone and DHEA-S levels were not associated with CVD risk, but high estrogen levels were associated with low risk. The risk for CVD in men whose estrogen levels were in the highest quartile was 0.68 times (95% CI, 0.50 to 0.92 times) that in the lowest quartile.

Academia and Clinic

  • The Allocation of Organs Donated by Altruistic Strangers

    • David Steinberg
    Ann Intern Med August 1, 2006 145:197-203

    According to an important principle of fairness, objective criteria, such as medical need, determine priority of access to a transplantable organ. Many people are willing to donate an organ to a stranger, and patients seek out these altruistic donors. Transactions between these parties threaten the principle of equity according to objective medical need. Altruistic donors should allocate their donated organs through a system that ensures access according to medical need rather than to the donor's emotional response to a particular patient's plight, identity, or circumstances. No such system exists at present.

Review

  • Meta-Analysis: Risk for Hypertension in Living Kidney Donors

    • Neil Boudville,
    • G. V. Ramesh Prasad,
    • Greg Knoll,
    • Norman Muirhead,
    • Heather Thiessen-Philbrook,
    • Robert C. Yang,
    • M. Patricia Rosas-Arellano,
    • Abdulrahman Housawi,
    • Amit X. Garg,
    • and for the Donor Nephrectomy Outcomes Research (DONOR) Network*
    Ann Intern Med August 1, 2006 145:185-196

    This review found 10 studies that compared the blood pressure of kidney donors and healthy adults of similar age, sex, and ethnicity. Within 5 to 10 years of donation, the average blood pressure of kidney donors was 5 mm Hg higher than that anticipated with normal aging.

Clinical Guidelines

  • Screening for Hemochromatosis: Recommendation Statement

    • U.S. Preventive Services Task Force*
    Ann Intern Med August 1, 2006 145:204-208

    The U.S. Preventive Services Task Force recommends against routine genetic screening for hereditary hemochromatosis in the asymptomatic general population.

  • Screening for Hereditary Hemochromatosis: A Systematic Review for the U.S. Preventive Services Task Force

    • Evelyn P. Whitlock,
    • Betsy A. Garlitz,
    • Emily L. Harris,
    • Tracy L. Beil,
    • and Paula R. Smith
    Ann Intern Med August 1, 2006 145:209-223

    This review supports the U.S. Preventive Services Task Force recommendation on routine genetic screening for hereditary hemochromatosis.

Editorials

  • How Can We Ethically Increase the Supply of Transplantable Organs?

    • James F. Childress
    Ann Intern Med August 1, 2006 145:224-225

    There are many “opportunities for action” to increase the supply of transplantable organs. The media tend to focus on the most controversial proposals, such as buying and selling organs, rather than the less dramatic but potentially very effective proposals, such as donation after circulatory determination of death. Furthermore, although living donation will be an important continuing source of organs—mainly kidneys—it clearly needs much more attention and oversight because of incomplete information about risks to donors and other ethical concerns.

  • Trials That Matter: Should We Routinely Measure Homocysteine Levels and “Treat” Mild Hyperhomocysteinemia?

    • Irwin H. Rosenberg and
    • Cynthia D. Mulrow
    Ann Intern Med August 1, 2006 145:226-227

    Several large trials have examined the reduction of total homocysteine levels as secondary stroke prevention in patients with vascular disease. In the Vitamin Intervention for Stroke Prevention (VISP) trial, a moderate reduction of total homocysteine levels had no statistically significant effect on vascular outcomes. Two larger, double-blind, placebo-controlled trials with longer follow-up were subsequently done: the Heart Outcomes Prevention Evaluation (HOPE) 2 and the Norwegian Vitamin (NORVIT) trial. What did these landmark trials show, and how will their findings affect clinical practice?

On Being a Patient

  • Paranoia over Privacy

    • Richard L. Neubauer
    Ann Intern Med August 1, 2006 145:228-229

    In 2002, diagnosed with peripheral neuropathy from primary amyloidosis at age 52, I became a patient. I decided to share my experiences with those impacted by my illness, thinking that this would possibly benefit them. But I was not prepared for the intricate set of privacy rules currently implemented as part of the Health Insurance Portability and Accountability Act (HIPAA). I fear that unless modified, this brave new world may do more harm than good.

Letters

  • Carotid Atherosclerosis and Rheumatoid Arthritis

    • Giovanni Targher
    Ann Intern Med August 1, 2006 145:231

  • Carotid Atherosclerosis and Rheumatoid Arthritis

    • Jane E. Salmon,
    • Stephen A. Paget,
    • and Mary J. Roman
    Ann Intern Med August 1, 2006 145:231

  • Treatment of Community-Acquired Methicillin-Resistant Staphylococcus aureus Infection

    • Kleper N.F. de Almeida and
    • Larry M. Bush
    Ann Intern Med August 1, 2006 145:231-232

  • Treatment of Community-Acquired Methicillin-Resistant Staphylococcus aureus Infection

    • James R. Johnson
    Ann Intern Med August 1, 2006 145:232

  • Treatment of Community-Acquired Methicillin-Resistant Staphylococcus aureus Infection

    • Henry M. Blumberg,
    • Susan M. Ray,
    • and Mark D. King
    Ann Intern Med August 1, 2006 145:232-233

  • Cost-Effectiveness of Statins Added to Aspirin Therapy

    • Mark K. Chelmowski
    Ann Intern Med August 1, 2006 145:233

  • Cost-Effectiveness of Statins Added to Aspirin Therapy

    • Michael Pignone
    Ann Intern Med August 1, 2006 145:233-234

  • Nephrogenic Fibrosing Dermopathy and High-Dose Erythropoietin Therapy

    • Sundararaman Swaminathan,
    • Iftikhar Ahmed,
    • James T. McCarthy,
    • Robert C. Albright,
    • Mark R. Pittelkow,
    • Noel M. Caplice,
    • Matthew D. Griffin,
    • and Nelson Leung
    Ann Intern Med August 1, 2006 145:234-235

  • Correction: Computerization Can Create Safety Hazards: A Bar-Coding Near Miss

    Ann Intern Med August 1, 2006 145:235

  • Correction: Bisphosphonates and Osteonecrosis of the Jaws

    Ann Intern Med August 1, 2006 145:235

Ad Libitum

Medical Notices

  • Medical Notices

    Ann Intern Med August 1, 2006 145:0

Summaries for Patients

  • The Effect of Educational Reminders on Blood Pressure in Veterans with Hypertension

    Ann Intern Med August 1, 2006 145:I-12

  • Screening for Hemochromatosis: Recommendations from the U.S. Preventive Services Task Force

    Ann Intern Med August 1, 2006 145:I-18

Commentary

  • Commentary: Paranoia over Privacy

    • Sylvia R. Cruess and
    • Richard L. Cruess
    Ann Intern Med August 1, 2006 145:229-230

    Dr. Neubauer highlights some of the more disturbing aspects of the Health Information Portability and Accountability Act of 1996, which can prevent health care professionals from meeting patients' legitimate needs. How should physicians respond when faced with legally enforceable rules and regulations that contravene their professional obligations?

« Previous | Next Issue »

This Issue

August 1, 2006; 145 (3)
  1. Articles
  2. Academia and Clinic
  3. Review
  4. Clinical Guidelines
  5. Editorials
  6. On Being a Patient
  7. Letters
  8. Ad Libitum
  9. Medical Notices
  10. Summaries for Patients
  11. Commentary

Search in this issue:

Current Issue

  1. November 3, 2009, 151 (9)
  1. Alert me to current issues